Show simple item record

dc.contributor.authorGunn, H
dc.contributor.authorStevens, KN
dc.contributor.authorCreanor, ES
dc.contributor.authorAndrade, J
dc.contributor.authorPaul, L
dc.contributor.authorMiller, L
dc.contributor.authorGreen, C
dc.contributor.authorEwings, P
dc.contributor.authorBarton, A
dc.contributor.authorBerrow, M
dc.contributor.authorVickery, J
dc.contributor.authorMarshall, B
dc.contributor.authorZajicek, J
dc.contributor.authorFreeman, JA
dc.date.accessioned2020-12-14T08:20:11Z
dc.date.issued2021-01-04
dc.description.abstractBackground Balance, mobility impairments and falls are problematic for people with Multiple Sclerosis (MS). The “Balance Right in MS (BRiMS)” intervention, a 13-week home and group-based exercise and education programme, aims to improve balance and minimise falls. This study aimed to evaluate the feasibility of undertaking a multi13 centre randomised controlled trial and to collect the necessary data to design a definitive trial. Methods This randomised controlled feasibility study recruited from four United Kingdom NHS clinical neurology services. Patients ≥18 years with secondary progressive MS (Expanded Disability Status Scale 4 to 7) reporting more than two falls in the preceding six months were recruited. Participants were block-randomised to either a manualised 13-week education and exercise programme (BRiMS) plus usual care, or usual care alone. Feasibility assessment evaluated recruitment and retention rates, adherence to group assignment and data completeness. Proposed outcomes for the definitive trial (including impact of MS, mobility, quality of life and falls) and economic data were collected at baseline, 13 and 27 weeks, and participants completed daily paper falls diaries. Results Fifty-six participants (mean age 59.7 years, 66% female, median EDSS 6.0) were recruited in five months; 30 randomised to the intervention group. Ten (18%) participants withdrew, seven from the intervention group. Two additional participants were lost to follow up at the final assessment point. Completion rates were >98% for all outcomes apart from the falls diary (return rate 62%). After adjusting for baseline score, mean intervention – usual care between-group differences for the potential primary outcomes at week 27 were: MS Walking Scale14 12v2: -7.7 (95% Confidence Interval [CI] -17.2 to 1.8) and MS Impact Scale-29v2: physical 0.6 (CI -7.8 to 9), psychological -0.4 (CI -9.9 to 9). In total, 715 falls were reported, rate ratio (intervention:usual care) for falls 0.81 (0.41 to 2.26) and injurious falls 0.44 (0.41 to 2.23). Conclusions Procedures were practical, and retention, programme engagement and outcome completion rates satisfied a priori progression criteria. Challenges were experienced in completion and return of daily falls diaries. Refinement of methods for reporting falls is therefore required, but we consider a full trial to be feasible.en_GB
dc.description.sponsorshipNational Institute for Health Research (NIHR)en_GB
dc.identifier.citationVol. 7, article 2en_GB
dc.identifier.doi10.1186/s40814-020-00732-9
dc.identifier.grantnumber14/176/12en_GB
dc.identifier.urihttp://hdl.handle.net/10871/124027
dc.language.isoenen_GB
dc.publisherBMCen_GB
dc.rights© The Author(s). 2020 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
dc.rightsAuthor accepted manuscript replaced with published version by Caroline Huxtable on 2021-01-22
dc.subjectSecondary progressive multiple sclerosisen_GB
dc.subjectExerciseen_GB
dc.subjectSelf-managementen_GB
dc.subjectMobilityen_GB
dc.subjectAccidental fallsen_GB
dc.subjectBalanceen_GB
dc.subjectQuality of lifeen_GB
dc.subjectFeasibility Randomised Controlled Trialen_GB
dc.titleBalance Right in Multiple Sclerosis (BRiMS): a feasibility randomised controlled trial of a falls prevention programmeen_GB
dc.typeArticleen_GB
dc.date.available2020-12-14T08:20:11Z
dc.identifier.issn2055-5784
dc.descriptionThis is the final version. Available on open access from BMC via the DOI in this recorden_GB
dc.descriptionAvailability of data and materials: Individual participant data that underlie the results of this study will be made available (following de-identification) on a controlled access basis, subject to suitable data sharing agreements. Requests for data sharing should be made to the Chief Investigator (CI, Freeman) in the first instance. Requesters will be asked to complete an application form detailing specific requirements, rationale and proposed usage. Requests will be reviewed by the CI and study Sponsor who will consider the viability and suitability of the request and the credentials of the requester. Where access to requested data is granted, requesters will be asked to sign a data sharing agreement. Requested data will be made available, along with supporting documentation (e.g. data dictionary) on a secure server or via other secure data transfer method.
dc.identifier.journalPilot and Feasibility Studiesen_GB
dc.rights.urihttps://creativecommons.org/licenses/by/4.0/en_GB
dcterms.dateAccepted2020-11-23
rioxxterms.versionVoRen_GB
rioxxterms.licenseref.startdate2020-11-23
rioxxterms.typeJournal Article/Reviewen_GB
refterms.dateFCD2020-12-10T16:48:27Z
refterms.versionFCDAM
refterms.dateFOA2021-01-22T15:43:50Z
refterms.panelAen_GB


Files in this item

This item appears in the following Collection(s)

Show simple item record

© The Author(s). 2020 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License,
which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give
appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if
changes were made. The images or other third party material in this article are included in the article's Creative Commons
licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons
licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain
permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the
data made available in this article, unless otherwise stated in a credit line to the data.
Except where otherwise noted, this item's licence is described as © The Author(s). 2020 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.